Baolingbao Biology Co Ltd
002286
Company Profile
Business description
Baolingbao Biology Co Ltd is engaged in providing biotechnology products and services. The products of the company include oligosaccharide, carbohydrate, sugar alcohol, dietary fiber, starch series, syrup series, Prebiotics, and new sugar sources Dietary fiber Starch and modified starch and Animal Nutrition.
Contact
No. 1, East Outer Ring Road
National High-tech Industrial Development Zone
Dezhou
Yucheng
CHNT: +86 5348918658
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
1,395
Stocks News & Analysis
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
stocks
New production imminent for undervalued ASX gas play
LNG project receives first commissioning gas.
stocks
Going into earnings, is Tesla stock a buy, a sell, or fairly valued?
Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,305.20 | 21.40 | 0.23% |
| CAC 40 | 8,174.20 | 14.39 | -0.18% |
| DAX 40 | 23,830.99 | 441.20 | -1.82% |
| Dow JONES (US) | 46,190.61 | 238.37 | 0.52% |
| FTSE 100 | 9,354.57 | 81.52 | -0.86% |
| HKSE | 25,859.44 | 612.34 | 2.43% |
| NASDAQ | 22,679.97 | 117.44 | 0.52% |
| Nikkei 225 | 48,945.44 | 1,363.29 | 2.87% |
| NZX 50 Index | 13,324.92 | 35.71 | 0.27% |
| S&P 500 | 6,664.01 | 34.94 | 0.53% |
| S&P/ASX 200 | 9,010.70 | 22.50 | 0.25% |
| SSE Composite Index | 3,866.09 | 26.34 | 0.69% |